Liliane Clotilde Dzouemo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liliane Clotilde Dzouemo has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Gervais Mouthé Happi
Higher Technical Teachers Training College, University of Douala, Douala P.O. Box 2701, Cameroon
7 shared publications - Jean Duplex Wansi
Department of Chemistry, Faculty of Sciences, University of Douala, P.O. Box 24157, Douala, Cameroon
7 shared publications - Klev Gaïtan Sikam
Department of Chemistry, Faculty of Sciences, The University of Douala
5 shared publications - Shina Salau
Kwara State University
3 shared publications - Sikiru Akinyeye Ahmed
Department of Chemistry and Industrial Chemistry, Kwara State University, Malete, Nigeria
3 shared publications - Emmanuel Ngeufa Happi
Department of Chemistry, Faculty of Science, University of Douala, Douala, Cameroon
2 shared publications
Latest Publications
- 25 September 2024
- Published by Taylor & Francis in Natural Product Research
- Vol. 39 (24) , 7126-7134
Antiplasmodial specialised compounds from the leaves of Guarea glomerulata Harms (Meliaceae)
To the best of our knowledge, this is the first chemical study of Guarea glomerulata that led to the isolation and characterisation of nine distinct compounds from its methanolic leaves extract including one new trinortriterpenoid glomerulatin along with eight known compounds amongst which five compounds namely azadirone, oleanolic acid, sericoside, cleomiscosin D and griffonin reported for the first time from the genus Guarea. All the isolated compounds have been evaluated in vitro for their antiplasmodial potency against the chloroquine-sensitive strain P. falciparum 3D7. The results showed that glomerulatin and azadirone were the most active compounds with IC50 values of 1.02 ± 0.2 μM and 1.48 ± 0.4 μM, respectively. This study enriches the chemistry of the genus Guarea and further supports the identification of Meliaceae plants as a good source of antiplasmodial candidates for the development of new potent drugs against malaria.
- 25 September 2024
- Published by Taylor & Francis in Natural Product Research
- Vol. 39 (24) , 7126-7134
Antiplasmodial specialised compounds from the leaves of Guarea glomerulata Harms (Meliaceae)
To the best of our knowledge, this is the first chemical study of Guarea glomerulata that led to the isolation and characterisation of nine distinct compounds from its methanolic leaves extract including one new trinortriterpenoid glomerulatin along with eight known compounds amongst which five compounds namely azadirone, oleanolic acid, sericoside, cleomiscosin D and griffonin reported for the first time from the genus Guarea. All the isolated compounds have been evaluated in vitro for their antiplasmodial potency against the chloroquine-sensitive strain P. falciparum 3D7. The results showed that glomerulatin and azadirone were the most active compounds with IC50 values of 1.02 ± 0.2 μM and 1.48 ± 0.4 μM, respectively. This study enriches the chemistry of the genus Guarea and further supports the identification of Meliaceae plants as a good source of antiplasmodial candidates for the development of new potent drugs against malaria.
- Open Access
- 1 January 2023
- Published by Wiley in BioMed Research International
- Vol. 2023 (1)
Bioassay‐Guided Isolation of Antiplasmodial Compounds from Hypericum lanceolatum Lam. (Hypericaceae) and Their Cytotoxicity and Molecular Docking
In Cameroon, malaria is still the cause of several deaths yearly and leading to the continued search for new potent leads to fight against Plasmodium falciparum. Medicinal plants like Hypericum lanceolatum Lam. are introduced in local preparations for the treatment of affected people. The bioassay‐guided fractionation of the crude extract of the twigs and stem bark of H. lanceolatum Lam. led to the identification of the dichloromethane‐soluble fraction as the most active (with 32.6% of the parasite P. falciparum 3D7 survival) which was further purified by successive column chromatography to obtain four compounds identified by their spectrometric data as two xanthones 1,6‐dihydroxyxanthone (1) and norathyriol (2) and two triterpenes betulinic acid (3) and ursolic acid (4). In the antiplasmodial assay against P. falciparum 3D7, the triterpenoids 3 and 4 displayed the most significant potencies with IC50 values of 2.8 ± 0.8 μg/mL and 11.8 ± 3.2 μg/mL, respectively. Furthermore, both compounds were also the most cytotoxic against P388 cell lines with IC50 values of 6.8 ± 2.2 μg/mL and 2.5 ± 0.6 μg/mL, respectively. Further insights on the inhibition method of the bioactive compounds and their drug‐likeness were obtained from their molecular docking and ADMET studies. The results obtained help in identifying additional antiplasmodial agents from H. lanceolatum and support its use in folk medicine for the treatment of malaria. The plant might be considered as a promising source of new antiplasmodial candidates in new drug discovery.
- 1 January 2023
- Published by Wiley in BioMed Research International
- Vol. 2023 (1)
Open AccessBioassay‐Guided Isolation of Antiplasmodial Compounds from Hypericum lanceolatum Lam. (Hypericaceae) and Their Cytotoxicity and Molecular Docking
In Cameroon, malaria is still the cause of several deaths yearly and leading to the continued search for new potent leads to fight against Plasmodium falciparum. Medicinal plants like Hypericum lanceolatum Lam. are introduced in local preparations for the treatment of affected people. The bioassay‐guided fractionation of the crude extract of the twigs and stem bark of H. lanceolatum Lam. led to the identification of the dichloromethane‐soluble fraction as the most active (with 32.6% of the parasite P. falciparum 3D7 survival) which was further purified by successive column chromatography to obtain four compounds identified by their spectrometric data as two xanthones 1,6‐dihydroxyxanthone (1) and norathyriol (2) and two triterpenes betulinic acid (3) and ursolic acid (4). In the antiplasmodial assay against P. falciparum 3D7, the triterpenoids 3 and 4 displayed the most significant potencies with IC50 values of 2.8 ± 0.8 μg/mL and 11.8 ± 3.2 μg/mL, respectively. Furthermore, both compounds were also the most cytotoxic against P388 cell lines with IC50 values of 6.8 ± 2.2 μg/mL and 2.5 ± 0.6 μg/mL, respectively. Further insights on the inhibition method of the bioactive compounds and their drug‐likeness were obtained from their molecular docking and ADMET studies. The results obtained help in identifying additional antiplasmodial agents from H. lanceolatum and support its use in folk medicine for the treatment of malaria. The plant might be considered as a promising source of new antiplasmodial candidates in new drug discovery.
- Open Access
- 22 November 2022
- Published by Hindawi Limited in Journal of Chemistry
- Vol. 2022, 1-10
Chemical Constituents of the Bark of Zanthoxylum gilletii (Rutaceae) and Their In Vitro Antiplasmodial and Molecular Docking Studies
The phytochemical investigations of the methanol extract of Zanthoxylum gilletii bark led to the isolation of thirteen compounds identified as two alkaloids including one acridone 5-hydroxynoracronycine (1) and one benzo [c] phenanthridine decarine (2), three lignans trans- and cis-fagaramide (3 and 4) and sesamin (5), two coumarins scoparone (6) and scopoletin (7), three pentacyclic triterpenoids fridelin (8), lupeol (9) and erythrodiol-3-O-palmitate (10), one phenolic compound vanillic acid (11) as well as two common steroids stigmasterol (12), and its derivative stigmasterol-3-O-β-D-glucopyranoside (13). The structures of all the isolated compounds were elucidated by means of their spectroscopic and spectrometric data (1D, 2D-NMR, MS) as well as the comparison of these data with those reported in the literature. Except for compounds 9 and 1113, all the other isolated compounds are reported for the first time from Z. gilletii but have been already obtained from other Zanthoxylum species and in the Rutaceae family. Compounds 1, 35, and 9 were tested in vitro for their antiplasmodial potencies against Plasmodium falciparum 3D7, and the results revealed that all the tested compounds displayed an inhibition between 51.89 and 54.69 while only the mixture of 3+4 gave an IC50 lower than 10 000nM (IC50=1333nM). Furthermore, all the compounds have been evaluated in silico for their ability to inhibit the Plasmodium falciparum dihydroorotate dehydrogenase 5TBO. Sesamin (5) showed the greatest affinity to the antiplasmodium receptor than artemether® and chloroquine®. Further recorded data from their ADMET study, as well as their chemotaxonomy, are also discussed herein. The present study provides further information to enrich the chemistry of Z. gilletii and its qualification as an important source for good candidates in new antiplasmodial drug development.
- 22 November 2022
- Published by Hindawi Limited in Journal of Chemistry
- Vol. 2022, 1-10
Open AccessChemical Constituents of the Bark of Zanthoxylum gilletii (Rutaceae) and Their In Vitro Antiplasmodial and Molecular Docking Studies
The phytochemical investigations of the methanol extract of Zanthoxylum gilletii bark led to the isolation of thirteen compounds identified as two alkaloids including one acridone 5-hydroxynoracronycine (1) and one benzo [c] phenanthridine decarine (2), three lignans trans- and cis-fagaramide (3 and 4) and sesamin (5), two coumarins scoparone (6) and scopoletin (7), three pentacyclic triterpenoids fridelin (8), lupeol (9) and erythrodiol-3-O-palmitate (10), one phenolic compound vanillic acid (11) as well as two common steroids stigmasterol (12), and its derivative stigmasterol-3-O-β-D-glucopyranoside (13). The structures of all the isolated compounds were elucidated by means of their spectroscopic and spectrometric data (1D, 2D-NMR, MS) as well as the comparison of these data with those reported in the literature. Except for compounds 9 and 1113, all the other isolated compounds are reported for the first time from Z. gilletii but have been already obtained from other Zanthoxylum species and in the Rutaceae family. Compounds 1, 35, and 9 were tested in vitro for their antiplasmodial potencies against Plasmodium falciparum 3D7, and the results revealed that all the tested compounds displayed an inhibition between 51.89 and 54.69 while only the mixture of 3+4 gave an IC50 lower than 10 000nM (IC50=1333nM). Furthermore, all the compounds have been evaluated in silico for their ability to inhibit the Plasmodium falciparum dihydroorotate dehydrogenase 5TBO. Sesamin (5) showed the greatest affinity to the antiplasmodium receptor than artemether® and chloroquine®. Further recorded data from their ADMET study, as well as their chemotaxonomy, are also discussed herein. The present study provides further information to enrich the chemistry of Z. gilletii and its qualification as an important source for good candidates in new antiplasmodial drug development.
- Open Access
- 26 October 2022
- Published by Hindawi Limited in Journal of Chemistry
- Vol. 2022, 1-21
Chemical Constituents from Uapaca guineensis (Phyllanthaceae), and the Computational Validation of Their Antileishmanial and Anti-inflammatory Potencies
From the chemical investigations of the root bark of Uapaca guineensis, nine distinct compounds (19) have been isolated and characterized as lupeol, betulin, betulinic acid, β-amyryl acetate, physcion, quercetin, rutin, β-sitosterol, and β-sitosterol-3-O-β-D-glucopyranoside, respectively. The structures of all the isolated compounds have been established using their NMR data as well as the comparison of those data with the ones reported in the literature. Interestingly, to the best of our knowledge, except for the lupane-type triterpenoids (13) and compounds 4 and 9, all the other compounds are reported for the first time from this genus. Since the plant is widely used for the treatment of skin diseases, leishmaniasis and inflammatory diseases, the antileishmanial and anti-inflammatory potencies of all the isolated compounds have been computationally validated through their ability to inhibit the receptors 1QCC and 2XOX (for the antileishmanial studies) and 6Y3C and 1CX2 (for the anti-inflammatory studies). Furthermore, the ADMET studies of compounds have been done to evaluate their drug-likeness. Results demonstrate that all the isolated compounds showed a better affinity for both receptors binding sites than the standard drugs miltefosine and aspirin. Moreover, the compounds would not cause addiction when used as lead molecules whereas, aspirin is predicted to violate the BBB over a long term of usage as a drug. This study gives additional information on the chemistry of U. guineensis and its classification as a potential source of good leads for the development of potent antileishmanial and anti-inflammatory drugs.
- 26 October 2022
- Published by Hindawi Limited in Journal of Chemistry
- Vol. 2022, 1-21
Open AccessChemical Constituents from Uapaca guineensis (Phyllanthaceae), and the Computational Validation of Their Antileishmanial and Anti-inflammatory Potencies
From the chemical investigations of the root bark of Uapaca guineensis, nine distinct compounds (19) have been isolated and characterized as lupeol, betulin, betulinic acid, β-amyryl acetate, physcion, quercetin, rutin, β-sitosterol, and β-sitosterol-3-O-β-D-glucopyranoside, respectively. The structures of all the isolated compounds have been established using their NMR data as well as the comparison of those data with the ones reported in the literature. Interestingly, to the best of our knowledge, except for the lupane-type triterpenoids (13) and compounds 4 and 9, all the other compounds are reported for the first time from this genus. Since the plant is widely used for the treatment of skin diseases, leishmaniasis and inflammatory diseases, the antileishmanial and anti-inflammatory potencies of all the isolated compounds have been computationally validated through their ability to inhibit the receptors 1QCC and 2XOX (for the antileishmanial studies) and 6Y3C and 1CX2 (for the anti-inflammatory studies). Furthermore, the ADMET studies of compounds have been done to evaluate their drug-likeness. Results demonstrate that all the isolated compounds showed a better affinity for both receptors binding sites than the standard drugs miltefosine and aspirin. Moreover, the compounds would not cause addiction when used as lead molecules whereas, aspirin is predicted to violate the BBB over a long term of usage as a drug. This study gives additional information on the chemistry of U. guineensis and its classification as a potential source of good leads for the development of potent antileishmanial and anti-inflammatory drugs.
- Open Access
- 21 September 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 3 (1) , 127-131
Benzo[c]phenanthridine alkaloids and glycosylated flavonoids from the roots of Zanthoxylum gilletii (Rutaceae)
The roots of Zanthoxylum gilletii have been chemically investigated and led to the isolation and characterization of nine compounds including three benzo[c]phenanthridine alkaloids oxychelerythrine (1), angoline (2) and arnottianamide (3); two glycosylated flavonoids hesperidin (4) and its analogue neohesperidin (5) along with four common specialized metabolites including sesamin (6), lupeol (7), β-sitosterol (8) and its derivative daucosterol (9). Their structures were established based on their recorded 1D and 2D-NMR data. Some compounds (1, 2, 3, 6 and 7) did not display a cytotoxic activity until the highest concentration of 200 μM against the human cell lines MCF-7 and A549. The chemotaxonomic relevance of this study has been discussed. To the best of our knowledge, except for the five compounds 3, 6-9, all the four others have been for the first time isolated from Z. gilletii (Rutaceae).
- 21 September 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 3 (1) , 127-131
Open AccessBenzo[c]phenanthridine alkaloids and glycosylated flavonoids from the roots of Zanthoxylum gilletii (Rutaceae)
The roots of Zanthoxylum gilletii have been chemically investigated and led to the isolation and characterization of nine compounds including three benzo[c]phenanthridine alkaloids oxychelerythrine (1), angoline (2) and arnottianamide (3); two glycosylated flavonoids hesperidin (4) and its analogue neohesperidin (5) along with four common specialized metabolites including sesamin (6), lupeol (7), β-sitosterol (8) and its derivative daucosterol (9). Their structures were established based on their recorded 1D and 2D-NMR data. Some compounds (1, 2, 3, 6 and 7) did not display a cytotoxic activity until the highest concentration of 200 μM against the human cell lines MCF-7 and A549. The chemotaxonomic relevance of this study has been discussed. To the best of our knowledge, except for the five compounds 3, 6-9, all the four others have been for the first time isolated from Z. gilletii (Rutaceae).
- Open Access
- 16 January 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 2 (2) , 129-141
Mushrooms (Basidiomycetes) as a significant source of biologically active compounds for malaria control
Mushrooms represent a large family of fleshy fungi that have been of high interest since ancient ages due to their medicinal and nutritional importance. Therefore, it can represent a significant source of bioactive compounds in malaria control. The few numbers of studies on in vitro antiplasmodial and insecticidal properties of their extracts and chemical constituents led to interesting results reported in numerous scientific publications. This review aims to provide a comprehensive compilation of literature up to 2021 on the antiplasmodial, insecticidal as well as cytotoxic chemical constituents of medicinal mushrooms that can help in the management of malaria both against the parasite Plasmodium falciparum and the mosquitoe Anopheles stephensis acting as a vector of malaria through its bites. For this purpose, some searches have been done in some online libraries using keywords like Basidiomycete, mushroom, malaria, Plasmodium, Anopheles and antiplasmodial without language restriction. Among the reported compounds, 51 selected ones displayed significant antiplasmodial potency with IC50 values lower than 10 μM against P. falciparum strains sensitive or resistant to chloroquine. For instance, ganoderic acid AW1 demonstrated a strong antiplasmodial activity with IC50 of 257.8 nM against P. falciparum D6, while strong activities were displayed by ganoweberianones A (IC50 = 0.050 μM) and B (IC50 = 0.46 μM) against P. falciparum K1. Moreover, some mushroom methanol extracts demonstrated good larvicidal and ovicidal activities against Anopheles stephensis. This paper provides further insights into the development of new antiplasmodial drugs or new potent eco-friendly pesticides to control mosquito vectors.
- 16 January 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 2 (2) , 129-141
Open AccessMushrooms (Basidiomycetes) as a significant source of biologically active compounds for malaria control
Mushrooms represent a large family of fleshy fungi that have been of high interest since ancient ages due to their medicinal and nutritional importance. Therefore, it can represent a significant source of bioactive compounds in malaria control. The few numbers of studies on in vitro antiplasmodial and insecticidal properties of their extracts and chemical constituents led to interesting results reported in numerous scientific publications. This review aims to provide a comprehensive compilation of literature up to 2021 on the antiplasmodial, insecticidal as well as cytotoxic chemical constituents of medicinal mushrooms that can help in the management of malaria both against the parasite Plasmodium falciparum and the mosquitoe Anopheles stephensis acting as a vector of malaria through its bites. For this purpose, some searches have been done in some online libraries using keywords like Basidiomycete, mushroom, malaria, Plasmodium, Anopheles and antiplasmodial without language restriction. Among the reported compounds, 51 selected ones displayed significant antiplasmodial potency with IC50 values lower than 10 μM against P. falciparum strains sensitive or resistant to chloroquine. For instance, ganoderic acid AW1 demonstrated a strong antiplasmodial activity with IC50 of 257.8 nM against P. falciparum D6, while strong activities were displayed by ganoweberianones A (IC50 = 0.050 μM) and B (IC50 = 0.46 μM) against P. falciparum K1. Moreover, some mushroom methanol extracts demonstrated good larvicidal and ovicidal activities against Anopheles stephensis. This paper provides further insights into the development of new antiplasmodial drugs or new potent eco-friendly pesticides to control mosquito vectors.
- Open Access
- 13 January 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 2 (3) , 322-326
Recent Advances on Pharmacology and Chemistry of Pycnanthus angolensis over the last decade (2012-2021)
Pycnanthus angolensis, widely known under its trade name "ilomba", is a medicinal plant from the family Myristicaceae that has occupied a prominent place in African traditional medicine for several decades; its broad application to treat numerous diseases, including malaria, bacterial infections and most recently COVID-19. The various chemical studies undertaken on the plant identified many classes of specialized compounds, including quinone-terpenoids, lignans and isoflavonoids, as the most abundant and bioactive components. The plant is defined as a major asset in developing new potent drugs and deserves further investigation in this regard. This mini-review aims to compile the newly documented findings on the traditional uses, phytochemistry and pharmacology of P. angolensis over the last decade from 2012 to 2021. In this regard, a literature search using the keyword Pycnanthus has been done without language restriction in numerous online libraries, including Scifinder, PubMed, Google Scholar, and only papers on Pycnanthus angolensis published after 2011 have been exploited during the writing.
- 13 January 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 2 (3) , 322-326
Open AccessRecent Advances on Pharmacology and Chemistry of Pycnanthus angolensis over the last decade (2012-2021)
Pycnanthus angolensis, widely known under its trade name "ilomba", is a medicinal plant from the family Myristicaceae that has occupied a prominent place in African traditional medicine for several decades; its broad application to treat numerous diseases, including malaria, bacterial infections and most recently COVID-19. The various chemical studies undertaken on the plant identified many classes of specialized compounds, including quinone-terpenoids, lignans and isoflavonoids, as the most abundant and bioactive components. The plant is defined as a major asset in developing new potent drugs and deserves further investigation in this regard. This mini-review aims to compile the newly documented findings on the traditional uses, phytochemistry and pharmacology of P. angolensis over the last decade from 2012 to 2021. In this regard, a literature search using the keyword Pycnanthus has been done without language restriction in numerous online libraries, including Scifinder, PubMed, Google Scholar, and only papers on Pycnanthus angolensis published after 2011 have been exploited during the writing.